CorVel (NASDAQ:CRVL) Upgraded by Wall Street Zen to “Buy” Rating

CorVel (NASDAQ:CRVL) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Saturday.

Separately, Weiss Ratings cut CorVel from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, April 6th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, CorVel presently has a consensus rating of “Sell”.

CorVel Trading Up 0.2%

Shares of CRVL opened at $61.75 on Friday. The business’s 50-day moving average price is $56.73 and its 200 day moving average price is $61.26. The stock has a market capitalization of $3.13 billion, a P/E ratio of 28.86 and a beta of 0.98. CorVel has a 1-year low of $44.83 and a 1-year high of $113.64.

CorVel (NASDAQ:CRVL) last issued its quarterly earnings results on Tuesday, May 19th. The business services provider reported $0.61 earnings per share for the quarter. The firm had revenue of $248.55 million for the quarter. CorVel had a return on equity of 29.92% and a net margin of 11.51%.

Insider Activity

In other news, insider Maxim Shishin sold 2,400 shares of CorVel stock in a transaction dated Monday, March 16th. The stock was sold at an average price of $54.00, for a total transaction of $129,600.00. Following the completion of the sale, the insider directly owned 7,050 shares in the company, valued at $380,700. The trade was a 25.40% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Jennifer Yoss sold 1,999 shares of CorVel stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $61.02, for a total value of $121,978.98. Following the sale, the vice president owned 2,173 shares of the company’s stock, valued at approximately $132,596.46. This represents a 47.91% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 44.56% of the stock is owned by insiders.

Institutional Investors Weigh In On CorVel

Institutional investors have recently made changes to their positions in the company. Federated Hermes Inc. lifted its holdings in shares of CorVel by 147.4% during the 3rd quarter. Federated Hermes Inc. now owns 381 shares of the business services provider’s stock valued at $29,000 after buying an additional 227 shares during the last quarter. Northwestern Mutual Wealth Management Co. bought a new position in shares of CorVel in the 3rd quarter valued at approximately $31,000. Los Angeles Capital Management LLC bought a new position in shares of CorVel in the 4th quarter valued at approximately $33,000. Eagle Bay Advisors LLC bought a new position in shares of CorVel in the 4th quarter valued at approximately $37,000. Finally, Hantz Financial Services Inc. raised its stake in shares of CorVel by 61.3% in the 3rd quarter. Hantz Financial Services Inc. now owns 500 shares of the business services provider’s stock valued at $39,000 after acquiring an additional 190 shares in the last quarter. 51.36% of the stock is currently owned by institutional investors and hedge funds.

CorVel Company Profile

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).